title: Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery.
abstract: Vaccines have been at the forefront of improving human health for over two centuries. The challenges faced in developing effective vaccines flow from complexities associated with the immune system and requirement of an efficient and safe adjuvant to induce a strong adaptive immune response. Development of an efficient vaccine formulation requires careful selection of a potent antigen, efficient adjuvant and route of delivery. Adjuvants are immunological agents that activate the antigen presenting cells (APCs) and elicit a strong immune response. In the past decade, the use of mesoporous silica nanoparticles (MSNs) has gained significant attention as potential delivery vehicles for various biomolecules. In this review, we aim to highlight the potential of MSNs as vaccine delivery vehicles and their ability to act as adjuvants. We have provided an overview on the latest progress on synthesis, adsorption and release kinetics and biocompatibility of MSNs as next generation antigen carriers and adjuvants. A comprehensive summary on the ability of MSNs to deliver antigens and elicit both humoral and cellular immune responses is provided. Finally, we give insight on fundamental challenges and some future prospects of these nanoparticles as adjuvants.
authors: Queensland Alliance for Agriculture and Food Innovation, The University of Queensland, Australia.
authors: Karishma T
authors: KT
authors: Mody
authors: Amirali
authors: A
authors: Popat
authors: Donna
authors: D
authors: Mahony
authors: Antonino S
authors: AS
authors: Cavallaro
authors: Chengzhong
authors: C
authors: Yu
authors: Neena
authors: N
authors: Mitter
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000818:Animals; D000938:Antigen-Presenting Cells / Q000378:metabolism; D000941:Antigens / Q000008:administration & dosage*; D002470:Cell Survival / Q000187:drug effects; D004337:Drug Carriers / Q000737:chemistry*; D006801:Humans; D053758:Nanoparticles / Q000737:chemistry* / Q000633:toxicity; D016062:Porosity; D012822:Silicon Dioxide / Q000737:chemistry*
chemical_list: D000276:Adjuvants, Immunologic; D000941:Antigens; D004337:Drug Carriers; D012822:Silicon Dioxide